172 related articles for article (PubMed ID: 30726791)
1. Association between Prescription and Control Status of Dyslipidemia and Hypertension among Japanese Patients with Diabetes.
Sakamoto M; Edo N; Takahashi S; Okamura E; Uno K; Morita K; Ishikawa T; Asahi K; Iseki K; Moriyama T; Yamagata K; Tsuruya K; Fujimoto S; Narita I; Konta T; Kondo M; Kimura K; Ohashi Y; Watanabe T; Tsukamoto K
J Atheroscler Thromb; 2019 Sep; 26(9):805-820. PubMed ID: 30726791
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with therapeutic goal attainment in patients with concomitant hypertension and dyslipidemia.
Chopra I; Kamal KM
Hosp Pract (1995); 2014 Apr; 42(2):77-88. PubMed ID: 24769787
[TBL] [Abstract][Full Text] [Related]
3. Control Status of Atherosclerotic Cardiovascular Risk Factors Among Japanese High-Risk Subjects:Analyses of a Japanese Health Check Database from 2008 to 2011.
Hasegawa K; Tsukamoto K; Kunimi M; Asahi K; Iseki K; Moriyama T; Yamagata K; Tsuruya K; Fujimoto S; Narita I; Konta T; Kondo M; Kimura K; Ohashi Y; Watanabe T
J Atheroscler Thromb; 2016 Aug; 23(8):991-1003. PubMed ID: 26961112
[TBL] [Abstract][Full Text] [Related]
4. Blood pressure and low-density lipoprotein cholesterol control status in Chinese hypertensive dyslipidemia patients during lipid-lowering therapy.
Yan X; Li Y; Dong Y; Wu Y; Li J; Bian R; Hu D
Lipids Health Dis; 2019 Jan; 18(1):32. PubMed ID: 30696435
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic goal attainment in patients with hypertension and dyslipidemia.
Johnson ML; Pietz K; Battleman DS; Beyth RJ
Med Care; 2006 Jan; 44(1):39-46. PubMed ID: 16365611
[TBL] [Abstract][Full Text] [Related]
6. Association between obesity and therapeutic goal attainment in patients with concomitant hypertension and dyslipidemia.
Chopra I; Kamal KM; Candrilli SD; Kanyongo G
Postgrad Med; 2014 Jan; 126(1):66-77. PubMed ID: 24393753
[TBL] [Abstract][Full Text] [Related]
7. [Status of cholesterol goal attainment for the primary and secondary prevention of atherosclerotic cardiovascular disease in dyslipidemia patients receiving lipid-lowering therapy: DYSIS-China subgroup analysis].
Li Y; Zhao SP; Ye P; Yan XW; Mu YM; Wei YD; Hu DY;
Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Aug; 44(8):665-70. PubMed ID: 27545124
[TBL] [Abstract][Full Text] [Related]
8. Sex disparity in the management and outcomes of dyslipidemia of diabetic patients in the Arabian Gulf: findings from the CEPHEUS study.
Al-Zakwani I; Al-Mahruqi F; Al-Rasadi K; Shehab A; Al Mahmeed W; Arafah M; Al-Hinai AT; Al Tamimi O; Al Awadhi M; Santos RD
Lipids Health Dis; 2018 Feb; 17(1):25. PubMed ID: 29402296
[TBL] [Abstract][Full Text] [Related]
9. Personal attributes that influence the adequate management of hypertension and dyslipidemia in patients with type 2 diabetes. Results from the DIAB-CORE Cooperation.
Rückert IM; Maier W; Mielck A; Schipf S; Völzke H; Kluttig A; Greiser KH; Berger K; Müller G; Ellert U; Neuhauser H; Rathmann W; Tamayo T; Moebus S; Andrich S; Meisinger C
Cardiovasc Diabetol; 2012 Oct; 11():120. PubMed ID: 23035799
[TBL] [Abstract][Full Text] [Related]
10. Hba1c, Blood Pressure, and Lipid Control in People with Diabetes: Japan Epidemiology Collaboration on Occupational Health Study.
Hu H; Hori A; Nishiura C; Sasaki N; Okazaki H; Nakagawa T; Honda T; Yamamoto S; Tomita K; Miyamoto T; Nagahama S; Uehara A; Yamamoto M; Murakami T; Shimizu C; Shimizu M; Eguchi M; Kochi T; Imai T; Okino A; Kuwahara K; Kashino I; Akter S; Kurotani K; Nanri A; Kabe I; Mizoue T; Kunugita N; Dohi S;
PLoS One; 2016; 11(7):e0159071. PubMed ID: 27437997
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, treatment, and control of dyslipidemia and hypertension in 4278 HIV outpatients.
Myerson M; Poltavskiy E; Armstrong EJ; Kim S; Sharp V; Bang H
J Acquir Immune Defic Syndr; 2014 Aug; 66(4):370-7. PubMed ID: 24732872
[TBL] [Abstract][Full Text] [Related]
12. Management of risk factors among ambulatory patients at high cardiovascular risk in Canada: a follow-up study.
Elbarasi EA; Goodman SG; Yan RT; Tan MK; Hackam DG; Leiter LA; Langer A; Yan AT;
Can J Cardiol; 2013 Dec; 29(12):1586-92. PubMed ID: 24041994
[TBL] [Abstract][Full Text] [Related]
13. The control of dyslipidemia in outpatient clinics in Greece (OLYMPIC) Study.
Diamantopoulos EJ; Athyros VG; Yfanti GK; Migdalis EN; Elisaf M; Vardas PE; Manolis AS; Karamitsos DT; Ganotakis ES; Hatseras D;
Angiology; 2005; 56(6):731-41. PubMed ID: 16327950
[TBL] [Abstract][Full Text] [Related]
14. Status of lipid management using lifestyle modification in Japanese adults: an analysis of the 2009 Japan Society of Ningen Dock database.
Takahashi E; Moriyama K; Yamakado M
Intern Med; 2013; 52(15):1681-6. PubMed ID: 23903499
[TBL] [Abstract][Full Text] [Related]
15. The significance of plasma adrenomedullin and calcitonin gene-related peptide concentration in patients with Type 2 diabetes mellitus who are treated for cardiovascular risk factors.
Charvat J; Svab P; Havlin J; Bilek R; Zamrazil V
Neuro Endocrinol Lett; 2014; 35(2):154-8. PubMed ID: 24878981
[TBL] [Abstract][Full Text] [Related]
16. Effect of bezafibrate on office, home and ambulatory blood pressure in hypertensive patients with dyslipidemia.
Ohta Y; Kawano Y; Iwashima Y; Hayashi S; Yoshihara F; Nakamura S
J Hum Hypertens; 2013 Jul; 27(7):417-20. PubMed ID: 23254592
[TBL] [Abstract][Full Text] [Related]
17. Impact of obtaining medications from pharmaceutical company assistance programs on therapeutic goals.
Trompeter JM; Havrda DE
Ann Pharmacother; 2009 Mar; 43(3):469-77. PubMed ID: 19240259
[TBL] [Abstract][Full Text] [Related]
18. Trends in cardiovascular risk factors among U.S. men and women with and without diabetes, 1988-2014.
Sun X; Du T
BMC Public Health; 2017 Nov; 17(1):893. PubMed ID: 29166886
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the assessment and management of cardiometabolic risk in patients with and without type 2 diabetes mellitus in Canadian primary care.
Teoh H; Després JP; Dufour R; Fitchett DH; Goldin L; Goodman SG; Harris SB; Langer A; Lau DC; Lonn EM; Mancini GB; McFarlane PA; Poirier P; Rabasa-Lhoret R; Tan MK; Leiter LA
Diabetes Obes Metab; 2013 Dec; 15(12):1093-100. PubMed ID: 23683111
[TBL] [Abstract][Full Text] [Related]
20. Gender-Related Differences in the Control of Cardiovascular Risk Factors in Primary Care for Elderly Patients With Type 2 Diabetes: A Cohort Study.
Al-Salameh A; Bucher S; Bauduceau B; Benattar-Zibi L; Berrut G; Bertin P; Corruble E; Danchin N; Derumeaux G; Doucet J; Falissard B; Forette F; Hanon O; Ourabah R; Pasquier F; Pinget M; Ringa V; Becquemont L
Can J Diabetes; 2018 Aug; 42(4):365-371.e2. PubMed ID: 29037572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
